StudyRareStudyRare

Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES)

Log in to star

Last updated Nov 3, 2026

Log in to add personal notes on this page.

A child presents with narrow horizontal palpebral fissures, drooping upper lids requiring chin elevation to see, and a skin fold ascending from the lower lid toward the nasal bridge. Eyelid surgery is planned for amblyopia prevention. Mother had identical features and went into menopause at 28.

AD; FOXL2 on 3q22.3, encoding a forkhead transcription factor; heterozygous loss-of-function variants in the gene or its regulatory region.

  • Eyelid malformation: present at birth; penetrance for the eye findings is complete, with one reported exception (a 19-alanine expansion that was asymptomatic in heterozygotes and caused BPES only when homozygous).
  • Premature ovarian insufficiency (POI) in females: age-related, with reduced penetrance and variability within and between families.
  • Type I and type II: historically, type I meant eyelid findings plus POI and type II meant eyelid findings only. Available data do not show a consistent genotype link: ovarian involvement varies with age and differs even among females with the same variant, so BPES is better treated as a single disorder.

FOXL2 encodes a 376-amino-acid transcription factor of the winged-helix/forkhead family; forkhead proteins help establish the body axis and build tissues from all three germ layers.

BPES is primarily a loss-of-function disorder. Depending on the variant, function may be lost through haploinsufficiency, impaired DNA binding, or a dominant-negative effect from misfolded FOXL2 protein. FOXL2 is a small single-exon gene. Nonsense and frameshift variants account for half of the coding-region findings, and expansions of its 14-residue polyalanine tract (to as many as 24 alanines) for about 24% of intragenic variants. Whole-gene deletions (8%), deletions of regulatory elements on the same allele (3%), and translocations (2%) also cause it.

No clinically relevant genotype-phenotype correlation is known, so the variant does not predict ovarian outcome. Surveillance follows puberty at 6- to 12-month intervals from age 10, then ovarian function in adult women.

For testing, the variant mix matters: standard targeted sequencing can miss polyalanine expansions, and deletions, regulatory changes, and rearrangements need copy-number testing, genome sequencing, or optical genome mapping. A negative sequencing result does not exclude BPES.

The four cardinal eyelid findings (the syndrome name spells them):

  • Blepharophimosis: narrowed horizontal palpebral fissure
  • Ptosis: bilateral, severe, often requiring frontalis sling
  • Epicanthus inversus: skin fold from lower lid up toward nasal bridge (reversed direction vs. typical epicanthus)
  • Telecanthus: increased distance between inner canthi

Plus, in type I females:

  • Premature ovarian insufficiency: secondary amenorrhea, low estrogen, elevated FSH, infertility before age 40
  • Clinical recognition of the four eyelid findings
  • FOXL2 sequencing; large deletions detected by CMA or MLPA
  • Distinction between type I and type II often awaits adolescent ovarian function
  • Ophthalmology / oculoplastics: surgical correction of ptosis and telecanthus typically in early childhood to prevent amblyopia (frontalis sling for severe ptosis); staged repair through adolescence
  • Females (any age, any type): monitor pubertal development and menstrual function; if POI emerges, hormone replacement and fertility counseling (IVF with donor eggs)
  • Genetic counseling: AD with 50% recurrence; type I → POI → fertility implications

"BPES Type 1 = Type 1 Trouble (eyes + ovaries)": type I has both eyelid and ovarian problems; type II is "type 2 = 2 eyes only."

The four-letter acronym IS the clinical exam: Blepharophimosis, Ptosis, Epicanthus inversus, Syndrome (with the silent fourth feature being telecanthus).

Reference Links